Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?
10.1016/j.antiviral.2005.11.005
Saved in:
Main Authors: | Cheng, Y., Seet, B.L., Ong, C.S.L., Wasser, S., Lim, S.G., Tan, T.M.C., Peter, F.J. |
---|---|
Other Authors: | OFFICE OF LIFE SCIENCES |
Format: | Article |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/27102 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
HEPATITIS B PREGENOMICS RNA SPLICING AND ITS ROLE IN VIRAL PERSISTANCE
by: LEE GUAN HUEI
Published: (2014) -
Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agents
by: Chen, Y., et al.
Published: (2011) -
Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1,3,4]-oxadiazoles as potential anti-hepatitis B virus agents
by: Chen, Y., et al.
Published: (2011) -
Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen
by: Penna, A, et al.
Published: (2020) -
Comparison of the technical and clinical performance of the Elecsys® HBsAg II Assay with the Architect®, AxSym®, and Advia® centaur HBsAg screening assays
by: Louisirirotchanakul, S., et al.
Published: (2011)